Abstract
Most pathological conditions that result in human diseases are associated with altered gene expression. With the advent of new technologies that might control gene expression and a broader knowledge of transcription factors and pathways, new strategies have emerged that offer promising first results for therapeutical and experimental purposes. This review will focus on different inflammatory conditions of the lung, in which targeting the transduction of involved genes have been successfully attempted.
Keywords: Allergy, Inflammation, Lung, Transcription, Antisense, Decoy, SiRNA
Current Drug Targets
Title: Targeting Transcription: A New Concept of Anti-Inflammatory Therapy of Airway Diseases
Volume: 7 Issue: 6
Author(s): D. Quarcoo and E. Hamelmann
Affiliation:
Keywords: Allergy, Inflammation, Lung, Transcription, Antisense, Decoy, SiRNA
Abstract: Most pathological conditions that result in human diseases are associated with altered gene expression. With the advent of new technologies that might control gene expression and a broader knowledge of transcription factors and pathways, new strategies have emerged that offer promising first results for therapeutical and experimental purposes. This review will focus on different inflammatory conditions of the lung, in which targeting the transduction of involved genes have been successfully attempted.
Export Options
About this article
Cite this article as:
Quarcoo D. and Hamelmann E., Targeting Transcription: A New Concept of Anti-Inflammatory Therapy of Airway Diseases, Current Drug Targets 2006; 7 (6) . https://dx.doi.org/10.2174/138945006777435326
DOI https://dx.doi.org/10.2174/138945006777435326 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Triple Negative Breast Cancer: How Neurokinin-1 Receptor Antagonists Could Be Used as a New Therapeutic Approach
Mini-Reviews in Medicinal Chemistry Overcoming Chemotherapy Resistance in High Grade Serous Ovarian Cancer
Current Cancer Therapy Reviews Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer
Combinatorial Chemistry & High Throughput Screening Development of personalized molecular therapy for acute myeloid leukemia
Current Pharmaceutical Biotechnology Recent Advances in Regulatory T Cell Therapy of Autoimmunity, Graft Rejection and Cancer
Recent Patents on Inflammation & Allergy Drug Discovery Advancing Metabolomics Research and Biomarker Application with Nanotechnology
Current Metabolomics Organ- and Cell-Type Specific Delivery of Kinase Inhibitors: A Novel Approach in the Development of Targeted Drugs
Current Molecular Pharmacology Recent Patents Concerning Modulators of Protein Kinase C
Recent Patents on DNA & Gene Sequences Monitoring T Cell Responses to Cancer Immunotherapy: Can We Now Identify Biomarkers Predicting Patients Who will be Responders
Current Cancer Therapy Reviews Imatinib Reduces the Vasculogenic Potential of Plastic Tumor Cells
Current Angiogenesis (Discontinued) Systematic Analysis of Large Screening Sets in Drug Discovery
Current Drug Discovery Technologies Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
Current Medicinal Chemistry - Anti-Cancer Agents Role of Hsp70 in Cancer Growth and Survival
Protein & Peptide Letters Extracellular Matrix, Integrins, and Mesenchymal Cell Function in the Airways
Current Drug Targets Role of mTOR in Hematological Malignancies
Current Cancer Therapy Reviews Bisphosphonates as Treatment of Bone Metastases
Current Pharmaceutical Design The Applicability of mTOR Inhibition in Solid Tumors
Current Cancer Drug Targets A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
Current Cancer Drug Targets CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors
Current Medicinal Chemistry Tumor-Targeted Drug Delivery with Aptamers
Current Medicinal Chemistry